1. Home
  2. KNSA vs DAN Comparison

KNSA vs DAN Comparison

Compare KNSA & DAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kiniksa Pharmaceuticals Ltd.

KNSA

Kiniksa Pharmaceuticals Ltd.

N/A

Current Price

$46.37

Market Cap

3.4B

Sector

Health Care

ML Signal

N/A

Logo Dana Incorporated

DAN

Dana Incorporated

N/A

Current Price

$31.76

Market Cap

3.3B

ML Signal

N/A

Company Overview

Basic Information
Metric
KNSA
DAN
Founded
2015
1904
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Auto Parts:O.E.M.
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
3.3B
IPO Year
2018
1998

Fundamental Metrics

Financial Performance
Metric
KNSA
DAN
Price
$46.37
$31.76
Analyst Decision
Strong Buy
Buy
Analyst Count
7
5
Target Price
$55.29
$35.00
AVG Volume (30 Days)
574.8K
1.4M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
1.50%
EPS Growth
225.00
264.10
EPS
0.75
0.64
Revenue
$677,564,000.00
$7,500,000,000.00
Revenue This Year
$38.01
$1.92
Revenue Next Year
$17.42
$3.60
P/E Ratio
$61.77
$50.00
Revenue Growth
60.09
N/A
52 Week Low
$18.26
$10.11
52 Week High
$49.12
$36.28

Technical Indicators

Market Signals
Indicator
KNSA
DAN
Relative Strength Index (RSI) 55.14 45.01
Support Level $40.47 $28.30
Resistance Level $46.48 $36.28
Average True Range (ATR) 2.16 1.23
MACD 0.00 -0.57
Stochastic Oscillator 64.75 17.65

Price Performance

Historical Comparison
KNSA
DAN

About KNSA Kiniksa Pharmaceuticals Ltd.

Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.

About DAN Dana Incorporated

Dana Inc is engaged in the designing and manufacturing of efficient propulsion and energy-management solutions that power vehicles and machines in all mobility markets across the globe. The company has four operating segments: Light Vehicles, Power Technologies, Commercial Vehicle, and Off-Highway. The Light Vehicles segment generates the majority portion of revenue by providing products to support light vehicle OEMs. Its products are designed for light trucks, SUVs, CUVs, vans, and passenger cars.

Share on Social Networks: